Woman working in lab
Announcement

The FDA approved our long-acting C5 complement inhibitor for adults with generalized myasthenia gravis. Read more about our latest approval.

Inspired Every Day

The work we do is guided by people living with rare and devastating diseases. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives.

SEE THEIR STORIES
  • Tanner, diagnosed with HPP at 4 days old, with a stuffed animal

    My hope for Tanner in the future is that he enters into adulthood. I kind of hope that he will be a doctor and maybe help kids like doctors have helped him.”

    RENE, MOM OF TANNER

    LIVING WITH HPP

    TANNER
    LIVING WITH HPP

  • Roberta, diagnosed with gMG at 16 years old

    This experience has taught me to look at the small things that count. Now, I feel that I have something to look forward to and I am who I want to be.”

    ROBERTA

    LIVING WITH gMG

    ROBERTA
    LIVING WITH GMG

  • The Trendys, diagnosed at 17, 14, 11, and 9 with LAL-D

    Now we knew what we were up against, we knew we could fight.”

    REBECCA, MOM OF TRENDY BROTHERS

    LIVING WITH LAL-D

    THE TRENDY FAMILY
    LIVING WITH LAL-D

  • Chelsey, living with NMOSD, painting

    I don't define myself as having a rare disease. It’s part of my life, but it’s certainly not who I am.”

    CHELSEY

    LIVING WITH NMOSD

    CHELSEY
    LIVING WITH NMOSD

  • Donnan, diagnosed with aHUS at 39 years old, and his son

    I can chase my kids and play again. I think knowing what I have brings a peace to my life.”

    DONNAN

    LIVING WITH aHUS

    DONNAN
    LIVING WITH aHUS

Every day, those who live with rare diseases and devastating conditions inspire us to push the boundaries of medicine, technology, and healthcare services. Our goal is to transform their reality for the better.

5

APPROVED MEDICINES

7

RARE DISEASES & DEVASTATING CONDITIONS

25+

OFFICES WORLDWIDE

3000+

TALENTED COLLEAGUES

Everyday Stories

Text: Collaboration with the rare disease ecosystem

Rare diseases are inherently unique and not well understood, which creates a complex research environment. As a result, developing rare disease medicines requires collaboration with patients, health care professionals, advocates, investigators, pharmacists, health authorities, policymakers, and many others, who share our passion for advancing research and development to help transform lives.

Learn More
MORE NEWS

The World Health Organization estimates that one out of 15 people worldwide could be affected by a rare disease. For more information: https://bit.ly/2EhEfWG

Generalized myasthenia gravis (#gMG) is a rare autoimmune disorder characterized by loss of muscle function and severe muscle weakness. For further advice and support: https://myasthenia.org/ #RareDisease

We strive to ignite an inclusive environment where people belong because of their uniqueness and unleash their individuality and diversity to spur innovative breakthroughs for patients. Join us: https://jobs.alexion.com #hiring

 DYK… 80% of #RareDiseases are genetic, while others are the result of infection, allergies, and environmental causes, or are rare cancers. For more information and support, visit https://globalgenes.org/rare-disease-facts/

Text: 80% of rare diseases have identified genetic origins
At Alexion, you’re encouraged to take on the most daunting of challenges, settle for nothing less than transformation, and push the boundaries of what science has traditionally offered. Check out our career opportunities: jobs.alexion.com #hiring
Multiple images of people working in scientific lab setting
Jesse, diagnosed with gMG
I feel like tomorrow I can do something, whereas before, I didn’t feel like tomorrow was possible.”
JESSE LIVING WITH gMG